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Abstract
Aim: To compare relative efficacy and safety of mechanical compression devices (AutoPulse and
LUCAS) with manual compression in patients with cardiac arrest undergoing cardiopulmonary
resuscitation (CPR).
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Methods: For this Bayesian network meta-analysis, seven randomized controlled trials (RCTs)
were selected using PubMed/Medline, EMBASE, and CENTRAL (Inception- 31 October 2017).
For all the outcomes, median estimate of odds ratio (OR) from the posterior distribution with
corresponding 95% credible interval (Cr I) was calculated. Markov chain Monte Carlo (MCMC)
modeling was used to estimate the relative ranking probability of each intervention based on
surface under the cumulative ranking curve (SUCRA).
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Results: In analysis of 12, 908 patients with cardiac arrest [AutoPulse (2, 608 patients); LUCAS
(3, 308 patients) and manual compression (6, 992 patients)], manual compression improved
survival at 30 days or hospital discharge (OR, 1.40, 95% Cr 1,1.09–1.94), and neurological
recovery (OR, 1.51, 95% Cr 1,1.06–2.39) compared to AutoPulse. There were no differences
between LUCAS and AutoPulse with regards to survival to hospital admission, neurological
recovery or return of spontaneous circulation (ROSC). Manual compression reduced the risk of
pneumothorax (OR, 0.56, 95% Cr I, 0.33–0.97); while, both manual compression (OR, 0.15, 95%
Cr I, 0.01–0.73) and LUCAS (OR, 0.07, 95% Cr I, 0.00–0.43) reduced the risk of hematoma
formation compared to AutoPulse. Probability analysis ranked manual compression as the most
effective treatment for improving survival at 30 days or hospital discharge (SUCRA, 84%).
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Conclusions: Manual compression is more effective than AutoPulse and comparable to LUCAS
in improving survival at 30 days or hospital discharge and neurological recovery. Manual
compression had lesser risk of pneumothorax or hematoma formation compared to AutoPulse.
Keywords
Compression devices; Cardiac arrest; Network meta-analysis

Introduction

Author Manuscript

Sudden cardiac arrest accounts for substantial mortality and morbidity worldwide. The
estimated incidence of out of hospital cardiac arrest (OHCA) is more than 350,000 per year
in the Unites States (US) [1], and more than 270,000 in the European Union [2]. The
estimated overall survival rate in the US is as low as 12% [1]. Early initiation of high quality
chest compressions is considered the essential component of successful cardiopulmonary
resuscitation (CPR) for enhancing survival among cardiac arrest victims [3,4]. The European
Resuscitation Council (ERC) and the American Heart Association (AHA) recommend
quality CPR with chest compressions delivered at a rate of 100–120/ min with a depth of at
least 5 cm [1,2]. These requirements are usually difficult to meet due to limited man power,
fatigue, competing tasks and access to the patient, which consequently may lead to
suboptimal CPR.
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To meet the required specifications, the Food and Drug Administration (USA) approved two
mechanical compression devices: AutoPulse (Zoll Medical Corporation, Chelmsford, MA,
USA) and LUCAS (Physio-Control/Jolife AB, Lund, Sweden) to perform chest
compression. There is a noticeable inconsistency in the published literature with regards to
efficacy of these devices. Various randomized controlled trials (RCTs) could not
demonstrate a survival benefit of mechanical compression over manual compression,
whereas, there is substantial observational data which suggested that mechanical CPR could
improve survival to hospital admission rates [5]. Furthermore, there is paucity of data related
to safety profiles of these devices. This discrepancy in literature calls for assessment of
relative efficacy and safety of mechanical compression devices and manual compression in
patients with cardiac arrest. To fill this knowledge gap, we performed a Bayesian network
meta-analysis to compare AutoPulse, LUCAS and manual compression in this subset of
patients.

Methods
Author Manuscript

This meta-analysis followed the Cochrane Collaboration group, and PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-Analysis) Extension for Network Metaanalyses guidelines [6,7].
Inclusion criteria
Eligible studies were RCTs which compared AutoPulse, LUCAS and manual Compression
in subjects with cardiac arrest (both OHCA and In Hospital Cardiac Arrest (IHCA)). The
studies had to report at least one clinical event among desired outcomes in adult population.
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There were no restrictions on sample size, comorbidities, initial rhythm or follow up
duration. Two authors (MUK and ST) screened the search results based on priori criteria.
The entire process was done under the supervision of third author (SUK).
Data sources and searches
Two authors (ANL and MUK) searched MEDLINE, EMBASE and CENTRAL from
Inception to 31 October 2017. The review of the bibliographies of the relevant articles was
also performed. The search was restricted to full text articles, humans and RCTs. There was
no restriction on language or publication year. The key search words were:
“cardiopulmonary resuscitation”, “CPR”, “cardiac arrest”, “mechanical compression
devices”, “AutoPulse” and “LUCAS”. The search results were downloaded to Endnote
(Thompson ISI ResearchSoft, Philadelphia, Pennsylvania, USA) and duplicates were
removed manually and through EndNote.
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Data extraction and quality assessment
Two authors (ST and MZK) performed data abstraction on a prespecified data collection
form. The following information was extracted: baseline characteristics of the participants,
events, non-events, sample size, and follow-up duration. We preferred outcomes from
intention to treat analyses. When available, adjusted estimates were extracted. We also
reviewed study protocols and appendices for additional information. The accuracy of data
was appraised by third author, ANL. The Cochrane bias risk assessment tool was used for
quality assessment and bias risk assessment was done at study level [8] (Supplementary
Table S1).
Outcome measures
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The primary outcome was survival at 30 days or hospital discharge. The secondary outcomes
were survival to hospital admission, return of spontaneous circulation (ROSC), neurological
recovery, visceral damage, sternal or rib fracture, pneumothorax, and hematoma formation.
There was variation in definition of neurological recovery. Three studies reported
improvement in neurological function through cerebral performance category (CPC), while
one study assessed neurological improvement by modified Rankin Scale (mRS). We defined
neurological recovery as CPC score 1 or 2, or mRS ≤ 3. The definitions of the other
endpoints were taken as reported in the trials.
Statistical analysis
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The Bayesian network meta-analysis is a superior statistical approach to traditional metaanalysis due to its ability to pool data related to multiple treatments concurrently, which
allows greater flexibility to use complex models with a more natural interpretation [9]. This
strategy can rank treatments according to their relative efficacy and safety, facilitating
predictive statements to be made regarding a specific problem and consequently improving
evidence-based decision making.
The Bayesian network meta-analysis was performed using NetMetaXL 1.6.1 (Canadian
Agency for Drugs and Technologies in Health; Ottawa, Canada) and winBUGS 1.4.3 (MRC
Biostatistics Unit; Cambridge, United Kingdom). The random effects model was selected for
Resuscitation. Author manuscript; available in PMC 2019 September 01.
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interpretation of results for its more conservative estimates. The analyses were conducted
with vague priors and informative priors separately to assess for the appropriateness of the
model. For random effects vague priors, we assumed use the following priors: sd~dunif
(0,2); where dunif is the density function of the uniform distribution, sd is the vector of
standard deviations, and 0 and 2 describe minimum and maximum vector of quantiles,
respectively. For informative variance prior, all-cause mortality informative priors were
selected based on non-pharmacological intervention with objective outcomes.
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NetMetaXL uses these selections and bases the informative variance priors on evidence on
the extent of heterogeneity noticed in prior metaanalyses, as reported in Turner et al [10].
For all analyses, we assumed vague priors on baseline [dnorm (0, 10,000)] and basic
parameters [dnorm (0, 10,000)], where function “dnorm” return the value of the probability
density function for the normal distribution based on given parameters. Since informative
priors, when used properly, can improve modeling efficiency by providing solutions to
computational issues, we ultimately applied predictive distributions (informative variance
priors) to random effects analyses [10,11]. For all the outcomes, we achieved convergence at
20,000 iterations and autocorrelation was checked and confirmed. The inconsistency was
assessed by comparing the deviance residuals and DIC statistics in fitted consistency and
inconsistency models [12].
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We calculated median estimate of odds ratio (OR) from the posterior distribution and
reported it with 2.5th to the 97.5th centiles of the distribution [95% credible interval (Cr I)].
The assessment of between- study variances was interpreted as suggested by Turner et al:
low (τ2 = 0.04), moderate (τ2 = 0.14) and high (τ2 = 0.40) [10]. Markov chain Monte Carlo
(MCMC) modeling was used to calculate the relative ranking probability of each
intervention. “Rankograms” along with surface under the cumulative ranking curve
(SUCRA) were provided to compare hierarchy of efficacy and safety of the interventions
[13]. The SUCRA is a numeric presentation of the overall ranking and demonstrates a single
number associated with each treatment. The SUCRA values range from 0 to 100%. The
higher the SUCRA value, and the closer to 100%, the higher the likelihood that a therapy is
in the top rank or highly effective; the closer to 0 the SUCRA value, the more likely that a
therapy is in the bottom rank or ineffective.

Results
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A total of 1994 articles were retrieved after electronic data base search and review of
bibliographies; of which —1159 were duplicates, and 828 were removed based on title,
abstract, study design, unwanted comparisons or undesired outcomes. Ultimately seven trials
were incorporated into this meta-analysis (Fig. 1). In total 12,908 cardiac arrest patients
[AutoPulse (2, 608 patients); LUCAS (3, 308 patients) and manual compression (6, 992
patients)] participated in this meta-analysis. The mean age of the participants was 68 ± 3
years, 64% were men, 28% had cardiac arrest due to ventricular arrhythmia, 25% had
pulseless electrical activity and 37% had asystole. The trial by Koster et al. was the only
study which assessed the interventions in both OHCA and IHCA patients [14], while the rest
of the studies enrolled exclusively subjects succumbing to OHCA (Table 1).
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In the network meta-analysis, manual compression improved survival at 30 days or hospital
discharge (OR, 1.40, 95% Cr I, 1.09–1.94) and neurological recovery (OR, 1.51, 95% Cr I,
1.06–2.39) when compared to AutoPulse. There were no differences between manual
compression and LUCAS or among LUCAS and AutoPulse with regards to survival at 30
days or hospital discharge or neurological recovery. All three interventions showed identical
benefits with regards to survival to hospital admission or ROSC (Fig. 2). Compared to
AutoPulse, manual compression was associated with 44% relative risk reduction of
pneumothorax (OR, 0.56, 95% Cr I, 0.33–0.97) and 85% lesser risk of hematoma formation
(OR, 0.15, 95% Cr I, 0.01–0.73). LUCAS had significant 93% reduced risk of hematoma
formation compared to AutoPulse (OR, 0.07, 95% Cr I, 0.00–0.43) (Fig. 3). All of the three
interventions could not demonstrate differences with regards to visceral damage, tension
pneumothorax or rib or sternal fractures.
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Probability analysis ranked manual compression as the most effective intervention for
having the highest probability of survival at 30 days or hospital discharge (SUCRA, 84%),
survival to hospital admission (SUCRA, 77%), or neurological improvement (SUCRA,
87%) (Fig. 4). With regards to safety profile, AutoPulse had the lowest probability of having
visceral damage (SUCRA, 56%), whereas, manual compression was ranked safest with
regards to tension pneumothorax (SUCRA, 71%) (Fig. 5).

Discussion
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In this network meta-analysis of seven trials involving 12,908 patients subjected to CPR
following cardiac arrest, manual compression when compared to AutoPulse improved the
rates of survival at 30 days or hospital discharge by 60% and neurological recovery by 49%.
LUCAS and AutoPulse shared similar efficacy profile in terms of survival at 30 days or
hospital discharge, survival to hospital admission, ROSC and neurological recovery.
Similarly, there were no differences between manual compression and LUCAS with regards
to efficacy. Manual compression had lesser risk of pneumothorax or hematoma formation
compared to AutoPulse; while, LUCAS showed superior safety in terms of hematoma
formation compared to AutoPulse. Probability analysis ranked manual compression as the
most effective strategy to improve survival at 30 days or hospital discharge, survival to
hospital admission, and neurological recovery, followed by LUCAS as the second best
strategy. Manual compression had the lowest probability of causing pneumothorax, whereas
AutoPulse had the lowest probability of being safe in terms of pneumothorax, tension
pneumothorax, hematoma formation and rib or sternal fractures.
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The AHA and ERC consider mechanical compression acceptable for continuing CPR during
transportation or during coronary revascularization [15,16]. However, RCTs have failed to
demonstrate survival benefit with mechanical compression devices. The possible
explanations for this observation are multiple. Firstly, compared to manual compression,
device positioning interrupts the continuity of chest compression and can potentially prolong
the time to first shock delivery. In the pioneer ASPIRE (AutoPulse Assisted Prehospital
International Resuscitation) trial, which was discontinued prematurely due to unfavorable
neurological and survival outcomes with AutoPulse, the mean time to first shock in
ventricular fibrillation was prolonged by 2.1 min in the AutoPulse group [17]. In the CIRC
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(Circulation Improving Resuscitation Care) trial and LINC (LUCAS in Cardiac Arrest) trial
the delay in first shock delivery was 1–1.5 min longer with device than with manual
compression [18,19]. The prolongation of both the compression free duration and the time to
first shock may compromise the cerebral and cardiac perfusion and consequently result in
poor neurological and survival outcomes.
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Second, not all patients can be fitted into the available mechanical devices. In LINC trial,
3.5% patients could not fit the device due to either increased body habitus (2.3%) or being
too small (1.2%); and only 95% patients were able to receive LUCAS [18]. This factor
might further delay the deployment of the device and thus compromise the outcomes. Third,
the CPR quality feedback was not up to the mark in some of the studies. CPR feedback
devices are critical component to assess quality of CPR during cardiac arrest and helps in
adjustment of chest compressions at the bed side. The PARAMEDIC trial (The Prehospital
Randomized Assessment of A Mechanical Compression Device in Cardiac Arrest) cited this
as a major limitation and highlights the sparsity of data with regards to quality assessment of
these devices [20].
Fourth, there was a substantial variability in study specified protocols which might have had
some effects on the observed outcomes. To address the issue of interruptions to CPR, the
LINC and CIRC trials trained providers with specific attention to reducing the interruption
to CPR that occurs while deploying the device. Differences in protocol driven sequences
might bias the effects of the interventions.
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Finally, the majority of trials did not comment on the safety hazards of these devices. This
issue was brought to attention by Koster and colleagues [14]. Their study was the first RCT
powered to assess the safety outcomes among AutoPulse, LUCAS and manual compression.
Total of three patients died due to resuscitation related hazards: two patients in LUCAS arm
had liver rupture and massive hemorrhage and one patient with AutoPulse had tension
pneumothorax with air embolism causing the stroke. Furthermore, a higher rate of serious
visceral injuries occurred with AutoPulse (11.6%), followed by LUCAS (7.4%) or manual
compression (6.4%). These findings raise safety concerns since these complications can
further compromise an already severely jeopardized hemodynamic state; and may contribute
to increased mortality.
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We compare our report with previous traditional meta-analyses which grouped mechanical
compression devices together and hence could not assess the individual risks associated with
these devices. Hui L and colleagues pooled 12 studies (11,162 patients) and showed no
difference between manual compression and mechanical compression devices in terms of
neurological outcomes, survival to hospital admission or discharge [21]. This study had
certain short comings. First, the authors included eight RCTs, three prospective cohort
studies and one descriptive controlled trial; and hence, the study was subjected to bias
inherent to observational data (selection, attrition and calculation bias). Moreover, they
combined Thumper and vest CPR studies along with LUCAS and AutoPulse, whereas, we
focused on contemporary FDA approved devices in this review. Another review by Bonnes
et al. included 20 studies (21,363 patients), out of which 15 were non randomized studies
and 5 were RCTs [5]. The authors concluded that although observational data endorsed
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mechanical compression, high quality RCTs did not favor mechanical compression over
manual CPR. This study did not assess safety outcomes among different devices. Our metaanalysis is the only network meta-analysis, to our knowledge, which has not only assessed
the safety profile of these devices, but we also utilized the superior Bayesian statistical
approach to compare the interventions by keeping relevant outcomes in focus.
This study also has certain limitations. First, like any meta-analysis, there is noticeable
heterogeneity with regards to baseline characteristics of the participants, co-morbidities,
study specific resuscitation protocols, definition of the outcomes and follow up duration.
Second, as reported earlier there was variation in the timing of device application, quality of
CPR, lack of CPR feed-back and post resuscitation management. Finally, these studies are
affected by performance bias due to open label design.
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In conclusion, CPR with manual compression showed better survival at 30 days or hospital
discharge and neurological outcomes than AutoPulse; while manual compression had similar
efficacy profile to LUCAS. These benefits may be attributable to CPR interruptions,
suboptimal mechanical device fit and device related adverse events such as pneumothorax or
hematoma formation. These findings question the routine applicability of the devices during
CPR and strongly endorse the notion that appropriate training of the providers with
conventional chest compressions might achieve superior outcomes with lesser complications
compared to mechanical compression. However, the authors also believe that this study
should provide industry with the incentive to engage in device improvement and address the
shortcoming of current devices. It is also possible that enhanced device training with
dedicated device personal can remedy CPR interruptions and delays even with current
devices.
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Fig. 1.

PRISMA flow diagram showing study selection process
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Fig. 2.

Forest plot showing comparison of intervention with regards to efficacy outcomes.
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Fig. 3.

Rankogram showing comparative ranking of each interventions for efficacy outcomes.
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Fig. 4.
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Forest plot showing comparison of intervention with regards to safety outcomes.
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Fig. 5.

Rankogram showing comparative ranking of each interventions for safety outcomes.
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Axelsson et al. [22]

Smekal et al. [23]

LINC [18]

CIRC [19]

PARAMEDIC [20]

Koster et al. [14]

Setting

ASPIRE [17]

Studies (Year)
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115
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AutoPulse
LUCAS
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Manual

2819

LUCAS

2099

Manual

2132

AutoPulse

1300

Manual

1289

LUCAS

75

Manual

73

LUCAS

159

Manual

169

LUCAS

394

Manual

373

AutoPulse

n

Manual

Groups

63

65

66

71
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67
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Age
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64

63
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67

66
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63
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64
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Men (%)

NA

NA

NA

43
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49

47

57

55

34

31

45

42

32

35

CPR by bystander (%)

34

26

25

23

22

21

24

29

30

N/A

N/A

30

32

31

32

VF /VT (%)

34

38

39

24

25

NA

NA

20

20

N/A

N/A

18

12

20

25

PEA (%)

18

23

24

50

49

NA

NA

47

46

N/A

N/A

34

34

42

40

Asystole (%)

Baseline characteristics of the studies, ASPIRE (AutoPulse Assisted Prehospital International Resuscitation); CIRC (Circulation Improving Resuscitation
Care); CPR (Cardiopulmonary Resuscitation); LINC (LUCAS in Cardiac Arrest); N/A (Not Available); PARAMEDIC (The Prehospital Randomized
Assessment of A Mechanical Compression Device in Cardiac Arrest); VF (Ventricular Fibrillation); VT (Ventricular Tachycardia); PEA (Pulseless
Electrical Activity).
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